INTERNATIONAL IMMUNOPHARMACOLOGY, cilt.3, sa.9, ss.1257-1260, 2003 (SCI-Expanded)
Leukotriene receptor antagonists are being used widely in the treatment of bronchial asthma. They have been shown to possess anti-inflammatory properties, but there is no sufficient data about their effects on polymorphonuclear leukocyte functions.